Company · CIK 2040475
Drugs Made In America Acquisition II Corp.
| CIK | 2040475 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 6770 — Blank Checks |
| Business address | NY |
| Listed | DMII (Nasdaq), DMIIR (Nasdaq), DMIIU (Nasdaq) |
| First annual or quarterly report | 2025-11-18 |
Offerings
1 registration| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-288791 | 2025-07-21 | 2025-09-25 | 6 |
Filings
7| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2025-09-25 | 424B4Final prospectus | 333-288791 | 0001213900-25-091724 |
| 2025-09-24 | EFFECTDeclared effective | 333-288791 | 9999999995-25-003076 |
| 2025-09-16 | S-1/AAmendment | 333-288791 | 0001213900-25-088044 |
| 2025-09-15 | S-1/AAmendment | 333-288791 | 0001213900-25-087444 |
| 2025-09-05 | S-1/AAmendment | 333-288791 | 0001213900-25-085167 |
| 2025-07-21 | S-1Registration filed | 333-288791 | 0001213900-25-065837 |
| 2025-03-19 | DRSDraft made public | 377-07803 | 0001213900-25-025159 |